ViewRay, Inc. (NASDAQ:VRAY) has received an average rating of “Buy” from the six research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating and five have issued a buy rating on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $10.00.
Several research firms have recently commented on VRAY. Mizuho reiterated a “buy” rating and issued a $12.00 price target on shares of ViewRay in a research report on Wednesday, October 25th. ValuEngine lowered shares of ViewRay from a “hold” rating to a “sell” rating in a research report on Friday, September 22nd. Finally, Aegis reiterated a “buy” rating and issued a $11.00 price target on shares of ViewRay in a research report on Saturday, July 22nd.
Several hedge funds have recently added to or reduced their stakes in the company. Russell Investments Group Ltd. grew its position in shares of ViewRay by 67.8% in the third quarter. Russell Investments Group Ltd. now owns 352,898 shares of the company’s stock valued at $2,033,000 after purchasing an additional 142,573 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in shares of ViewRay during the second quarter valued at approximately $237,000. California State Teachers Retirement System lifted its stake in shares of ViewRay by 280.5% during the second quarter. California State Teachers Retirement System now owns 51,819 shares of the company’s stock valued at $335,000 after buying an additional 38,200 shares during the period. The Manufacturers Life Insurance Company purchased a new position in shares of ViewRay during the second quarter valued at approximately $159,000. Finally, State Street Corp lifted its stake in shares of ViewRay by 631.7% during the second quarter. State Street Corp now owns 395,418 shares of the company’s stock valued at $2,555,000 after buying an additional 341,376 shares during the period. Institutional investors and hedge funds own 53.64% of the company’s stock.
WARNING: “Analysts Set ViewRay, Inc. (VRAY) Target Price at $10.00” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at https://ledgergazette.com/2017/11/07/analysts-set-viewray-inc-vray-target-price-at-10-00.html.
ViewRay (NASDAQ:VRAY) traded down $0.09 during midday trading on Thursday, reaching $8.31. The company had a trading volume of 584,627 shares, compared to its average volume of 718,454. The company has a debt-to-equity ratio of -2.62, a current ratio of 1.73 and a quick ratio of 1.45. ViewRay has a twelve month low of $2.67 and a twelve month high of $10.39.
ViewRay (NASDAQ:VRAY) last issued its earnings results on Monday, August 7th. The company reported ($0.26) earnings per share for the quarter, missing the consensus estimate of ($0.24) by ($0.02). The business had revenue of $0.70 million for the quarter, compared to the consensus estimate of $0.68 million. The company’s revenue for the quarter was up 133.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.32) EPS. sell-side analysts expect that ViewRay will post -0.81 earnings per share for the current year.
ViewRay Company Profile
ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.
Receive News & Ratings for ViewRay Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ViewRay Inc. and related companies with MarketBeat.com's FREE daily email newsletter.